| 摘要 |
The invention relates to the use of a compound acting as positive allosteric modulator of GABA<SUB>B </SUB>receptors in the treatment of GERD, regurgitation, IBS, dyspepsia, postoperative complaints and conditions associated with visceral discomfort/pain.
|
